| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2015PLoSO..1017695S |
| P356 | DOI | 10.1371/JOURNAL.PONE.0117695 |
| P932 | PMC publication ID | 4339376 |
| P698 | PubMed publication ID | 25710475 |
| P5875 | ResearchGate publication ID | 272842273 |
| P50 | author | Dayong Wang | Q84920224 |
| P2093 | author name string | Kai Liao | |
| Lingmei Sun | |||
| P2860 | cites work | Antifungal activity of magnolol and honokiol | Q28139407 |
| Antifungal chemical compounds identified using a C. elegans pathogenicity assay | Q28469125 | ||
| Therapeutic potential of thiazolidinedione-8 as an antibiofilm agent against Candida albicans | Q28538463 | ||
| Critical role of Bcr1-dependent adhesins in C. albicans biofilm formation in vitro and in vivo. | Q33250085 | ||
| Isogenic strain construction and gene mapping in Candida albicans. | Q33961115 | ||
| Retigeric acid B attenuates the virulence of Candida albicans via inhibiting adenylyl cyclase activity targeted by enhanced farnesol production | Q34358699 | ||
| Natural products as sources of new drugs over the period 1981-2002. | Q35184693 | ||
| Environmental sensing and signal transduction pathways regulating morphopathogenic determinants of Candida albicans | Q35856686 | ||
| Role for cell density in antifungal drug resistance in Candida albicans biofilms | Q35878982 | ||
| Candida albicans biofilms: more than filamentation | Q36167141 | ||
| How to build a biofilm: a fungal perspective | Q36630762 | ||
| Chemical screening identifies filastatin, a small molecule inhibitor of Candida albicans adhesion, morphogenesis, and pathogenesis. | Q37104113 | ||
| In vitro activities of retigeric acid B alone and in combination with azole antifungal agents against Candida albicans | Q37144780 | ||
| The Ras/cAMP/PKA signaling pathway and virulence in Candida albicans | Q37648692 | ||
| Genetic control of Candida albicans biofilm development | Q37824380 | ||
| Antifungal activity against Candida biofilms | Q38058720 | ||
| Key physiological differences in Candida albicans CDR1 induction by steroid hormones and antifungal drugs. | Q50718578 | ||
| Adhesive and Mammalian Transglutaminase Substrate Properties of Candida albicans Hwp1 | Q56019296 | ||
| Estimating the cost of nosocomial candidemia in the united states | Q73661994 | ||
| The role of natural products in drug discovery and development in the new millennium | Q82760733 | ||
| Comparative analysis of microorganism species succession on three implant surfaces with different roughness: an in vivo study | Q83744111 | ||
| Antimicrobial activity and cytotoxic effects of Magnolia dealbata and its active compounds | Q84953914 | ||
| Industrial natural product chemistry for drug discovery and development. | Q38154186 | ||
| Antifungal stewardship in invasive Candida infections | Q38198808 | ||
| Function of Candida albicans adhesin Hwp1 in biofilm formation. | Q38499591 | ||
| Curcumol induces HSC-T6 cell death through suppression of Bcl-2: involvement of PI3K and NF-κB pathways | Q38956603 | ||
| Comparative in vitro fungicidal activity of echinocandins against Candida albicans in peritoneal dialysis fluids | Q39526740 | ||
| Small-molecule inhibitors of the budded-to-hyphal-form transition in the pathogenic yeast Candida albicans | Q40443248 | ||
| Antifungal resistance trends towards the year 2000. Implications for therapy and new approaches | Q40878512 | ||
| Natural products in drug discovery and development | Q41334729 | ||
| Candida albicans biofilm on titanium: effect of peroxidase precoating. | Q41815484 | ||
| The synergy of honokiol and fluconazole against clinical isolates of azole-resistant Candida albicans | Q42948079 | ||
| Synergistic mechanisms of retigeric acid B and azoles against Candida albicans | Q43225263 | ||
| Candida albicans and non-C. albicans Candida species: comparison of biofilm production and metabolic activity in biofilms, and putative virulence properties of isolates from hospital environments and infections | Q44516466 | ||
| A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients. | Q44564495 | ||
| Plagiochin E, an antifungal bis(bibenzyl), exerts its antifungal activity through mitochondrial dysfunction-induced reactive oxygen species accumulation in Candida albicans. | Q46009842 | ||
| Multi-drug resistant oral Candida species isolated from HIV-positive patients in South Africa and Cameroon. | Q46082366 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Candida albicans | Q310443 |
| biofilm | Q467410 | ||
| P304 | page(s) | e0117695 | |
| P577 | publication date | 2015-02-24 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Effects of magnolol and honokiol on adhesion, yeast-hyphal transition, and formation of biofilm by Candida albicans | |
| P478 | volume | 10 |
| Q47549081 | Activity of gallic acid and its ester derivatives in Caenorhabditis elegans and zebrafish (Danio rerio) models |
| Q45370828 | Alizarin and Chrysazin Inhibit Biofilm and Hyphal Formation by Candida albicans |
| Q38840796 | An update on the use of C. elegans for preclinical drug discovery: screening and identifying anti-infective drugs |
| Q93007135 | Anti-Fungal Efficacy and Mechanisms of Flavonoids |
| Q40086401 | Antibiofilm and Antihyphal Activities of Cedar Leaf Essential Oil, Camphor, and Fenchone Derivatives against Candida albicans |
| Q49507389 | Antifungal Compounds against Candida Infections from Traditional Chinese Medicine |
| Q55312641 | Antifungal Effects of Saponin Extract from Rhizomes of Dioscorea panthaica Prain et Burk against Candida albicans. |
| Q37736301 | Antimicrobial Compounds Produced by Vaginal Lactobacillus crispatus Are Able to Strongly Inhibit Candida albicans Growth, Hyphal Formation and Regulate Virulence-related Gene Expressions |
| Q39015075 | Critical review on biofilm methods. |
| Q60937783 | Dioscin Inhibits Virulence Factors of |
| Q88362688 | Efficacy of 7-benzyloxyindole and other halogenated indoles to inhibit Candida albicans biofilm and hyphal formation |
| Q36239809 | Employment of methylene blue irradiated with laser light source in photodynamic inactivation of biofilm formed by Candida albicans strain resistant to fluconazole |
| Q47612555 | Honokiol Increases CD4+ T Cell Activation and Decreases TNF but Fails to Improve Survival Following Sepsis |
| Q36278629 | Honokiol induces reactive oxygen species-mediated apoptosis in Candida albicans through mitochondrial dysfunction |
| Q93099536 | Honokiol, magnolol and its monoacetyl derivative show strong anti-fungal effect on Fusarium isolates of clinical relevance |
| Q49679578 | In Vitro Antibiofilm Activity of Eucarobustol E against Candida albicans |
| Q41355300 | In vitro inhibitory activities of magnolol against Candida spp. |
| Q57154099 | Influence of Eugenia uniflora Extract on Adhesion to Human Buccal Epithelial Cells, Biofilm Formation, and Cell Surface Hydrophobicity of Candida spp. from the Oral Cavity of Kidney Transplant Recipients |
| Q36208305 | Inhibition of Candida albicans Biofilm Formation by the Synthetic Lactoferricin Derived Peptide hLF1-11. |
| Q48161979 | Inhibition of yeast-to-filamentous growth transitions in Candida albicans by a small molecule inducer of mammalian apoptosis |
| Q40347601 | Inhibitory effects of the essential oils α-longipinene and linalool on biofilm formation and hyphal growth of Candida albicans |
| Q40770175 | Insights into the mode of action of anticandidal herbal monoterpenoid geraniol reveal disruption of multiple MDR mechanisms and virulence attributes in Candida albicans |
| Q93030282 | Insights on the Multifunctional Activities of Magnolol |
| Q57296182 | Mannich base limits Candida albicans virulence by inactivating Ras-cAMP-PKA pathway |
| Q96685779 | Mechanisms of action of antimicrobial peptides ToAP2 and NDBP-5.7 against Candida albicans planktonic and biofilm cells |
| Q55511181 | Methodologies for in vitro and in vivo evaluation of efficacy of antifungal and antibiofilm agents and surface coatings against fungal biofilms. |
| Q57161198 | Promising Antifungal Targets Against Based on Ion Homeostasis |
| Q38833403 | Propolis: a potential natural product to fight Candida species infections |
| Q59128082 | Suppression of Fluconazole Resistant Biofilm Formation and Filamentation by Methylindole Derivatives |
| Q97883470 | Synergistic Effect of Berberine Hydrochloride and Fluconazole Against Candida albicans Resistant Isolates |
| Q36055716 | The calcineruin inhibitor cyclosporine a synergistically enhances the susceptibility of Candida albicans biofilms to fluconazole by multiple mechanisms |
| Q40091006 | Thymol has antifungal activity against Candida albicans during infection and maintains the innate immune response required for function of the p38 MAPK signaling pathway in Caenorhabditis elegans. |
| Q89559203 | Virulence and biofilms as promising targets in developing antipathogenic drugs against candidiasis |
| Q37379479 | microRNAs Involved in the Control of Innate Immunity in Candida Infected Caenorhabditis elegans |
Search more.